The International Research Conference Aims and Objectives
The International Research Conference is a federated organization dedicated to bringing together a significant number of diverse scholarly events for presentation
within the conference program. Events will run over a span of time during the conference depending on the number and length of the presentations.
With its high quality, it provides an exceptional value for students, academics and industry researchers.
International Conference on Pharmacovigilance and Clinical Trials
aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of
Pharmacovigilance and Clinical Trials.
It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations,
trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Pharmacovigilance and Clinical Trials.
Call for Contributions
Prospective authors are kindly encouraged to contribute to and help shape the conference through submissions of their research abstracts, papers and e-posters.
Also, high quality research contributions describing original and unpublished results of conceptual, constructive, empirical, experimental, or
theoretical work in all areas of Pharmacovigilance and Clinical Trials are cordially invited for presentation at the conference.
The conference solicits contributions of abstracts, papers and e-posters that address themes and topics of the conference, including figures, tables and references of
novel research materials.
Guidelines for Authors
Please ensure your submission meets the conference's strict guidelines for accepting scholarly papers.
Downloadable versions of the check list for
Full-Text Papers and
Abstract Papers.
Please refer to the
Paper Submission Guideline,
Abstract Submission Guideline and
Author Information
before submitting your paper.
Conference Proceedings
All submitted conference papers will be blind peer reviewed by three competent reviewers.
The peer-reviewed conference proceedings are indexed in the Open Science Index,
Google Scholar,
Semantic Scholar,
Zenedo,
BASE,
WorldCAT,
Sherpa/RoMEO,
and other index databases. Impact Factor Indicators.
Special Journal Issues
19. International Conference on Pharmacovigilance and Clinical Trials has teamed up with the Special Journal Issue on
Pharmacovigilance and Clinical Trials.
A number of selected high-impact full text papers will also be considered for the special journal issues.
All submitted papers will have the opportunity to be considered for this Special Journal Issue.
The paper selection will be carried out during the peer review process as well as at the conference presentation stage.
Submitted papers must not be under consideration by any other journal or publication.
The final decision for paper selection will be made based on peer review reports by the Guest Editors and the Editor-in-Chief jointly.
Selected full-text papers will be published online free of charge.
Conference Sponsor and Exhibitor Opportunities
The Conference offers the opportunity to become a conference sponsor or exhibitor.
To participate as a sponsor or exhibitor, please download and complete the
Conference Sponsorship Request Form.
Selected Papers
-
PredictionSCMS: The Implementation of an AI-Powered Supply Chain Management System
Ioannis Andrianakis, Vasileios Gkatas, Nikos Eleftheriadis, Alexios Ellinidis, Ermioni Avramidou
-
Optimizing Organizational Performance: The Critical Role of Headcount Budgeting in Strategic Alignment and Financial Stability
Shobhit Mittal
-
Retrieval Augmented Generation against the Machine: Merging Human Cyber Security Expertise with Generative AI
Brennan Lodge
-
A BIM-Based Approach to Assess COVID-19 Risk Management Regarding Indoor Air Ventilation and Pedestrian Dynamics
T. Delval, C. Sauvage, Q. Jullien, R. Viano, T. Diallo, B. Collignan, G. Picinbono
-
Physics of Decision for Polling Place Management: A Case Study from the 2020 USA Presidential Election
Nafe Moradkhani, Frederick Benaben, Benoit Montreuil, Ali Vatankhah Barenji, Dima Nazzal
-
CybeRisk Management in Banks: An Italian Case Study
E. Cenderelli, E. Bruno, G. Iacoviello, A. Lazzini
-
Time Series Simulation by Conditional Generative Adversarial Net
Rao Fu, Jie Chen, Shutian Zeng, Yiping Zhuang, Agus Sudjianto
-
Critical Psychosocial Risk Treatment for Engineers and Technicians
R. Berglund, T. Backström, M. Bellgran
-
Daily Site Risks Associated with Construction Projects and On-spot Corrective Measurements: Case Study of Revamping Projects in Kuwait Oil Company Fields Area
Yousef S. Al-Othman
-
Portfolio Management for Construction Company during Covid-19 Using AHP Technique
Sareh Rajabi, Salwa Bheiry
-
Risk Management Approach for a Secure and Performant Integration of Automated Drug Dispensing Systems in Hospitals
Hind Bouami, Patrick Millot
-
Banking Risk Management between the Prudential and the Operational Approaches
Mustapha Achibane, Imane Allam
-
Net Interest Margin of Cooperative Banks in Low Interest Rate Environment
Karolína Vozková, Matěj Kuc
-
Information Security Risk Management in IT-Based Process Virtualization: A Methodological Design Based on Action Research
Jefferson Camacho Mejía, Jenny Paola Forero Pachón, Luis Carlos Gómez Flórez
-
Measuring Banks’ Antifragility via Fuzzy Logic
Danielle Sandler dos Passos, Helder Coelho, Flávia Mori Sarti
Digital Program consists of the e-proceedings book which is available online-only
and includes the conference communications (proceedings abstracts and papers).
Registered participants can access the digitally available conference
proceedings ( and certificates ) by visiting their profile pages.
Concept of Pharmacovigilance and its Significance and Scope
Pre-Clinical and Clinical Trials
Clinical Trials on Drugs used in Various Disorders, Pharmacotherapy and Pharmacotherapeutics
Adverse Drug Reactions
Pharmacokinetics and Pharmacodynamics
Pharmacy Practices and its Challenges
Pharmacovigilance and Risk Management
Clinical Research and Statistics
Strategies for Growth in Pharma Environment
Good Pharmacovigilance Practice and Pharmacoepidemiology
Case Report in Clinical Trials
Clinical Pharmacology and Biopharmaceutics
Abstracts/Full-Text Paper Submission Deadline |
|
November 28, 2024 |
Notification of Acceptance/Rejection |
|
December 12, 2024 |
Final Paper (Camera Ready) Submission & Early Bird Registration Deadline |
|
February 11, 2025 |
Conference Dates |
|
March 10-11, 2025 |